Navigation Links
3 angelMD Startups Make Livestrong Big C Semi-finals
Date:7/24/2014

San Francisco, CA (PRWEB) July 24, 2014

Three companies from the angelMD network were chosen Wednesday to be semi-finalists in Livestrong’s Big C Competition. Out of 700 competition entrants, Chiron Health, Litesprite, and Decisive Health are each headed to the semi-final round. In this round twenty teams are invited to participate in Livestrong’s exclusive three-month accelerator program, complete with mentoring from thought-leaders and medical entrepreneurs from all over the country.

As part of the angelMD commitment to the Livestrong vision around the Big C competition, CTO Jens Francis will participate as a mentor.

“I’m excited to serve in a mentorship role. Livestrong has a terrific vision around supporting medical startups making an impact, and we are on board 100%," says Jens Francis. “I look forward to working with the innovative companies in their network.”

About Chiron Health
Chiron Health, based in Austin, Texas, is a unique telemedicine platform for outpatient follow-up care—with full regulatory and reimbursement support for physician practices. The company provides a secure technology platform that leverages the existing computers, tablets, and mobile devices that physicians and patients use every day, providing a high-touch telemedicine toolkit—including full reimbursement from private payers.

About Litesprite
Seattle-based Litesprite is a company dedicated to finding innovative ways to help people learn, develop, and maintain healthy habits. By combining proven medical treatments with the joy of games, Litesprite builds experiences that help people improve their health.

About Decisive Health
Led by Nathanael Rosidi, Ph.D., and Jonathan Shih, Ph.D, Decisive Health enables specialists to see more patients by improving the quality and efficiency of patient consultations. Decisive Health educates patients about recommended treatment options, predicts patient treatment preferences, and qualifies patients for procedures sooner. The company is based in San Francisco.

About angelMD
angelMD is an investment marketplace connecting physicians with innovative medical startups seeking capital investments, advisors, and users. Leading physicians from all over the US have joined the angelMD Clinical Advisory Board and Leaders Club to help source and evaluate opportunities in biotechnology, medical device and healthcare technology. For more information, visit http://www.angelmd.co.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12043772.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Expanded SPIE Photonics West 2014 Industry Track Offers More for Technology Commercialization Entrepreneurs, Startups, Investors, Executives
2. U.S.-Russia Innovation Corridor Hosts Biotech & IT Startups
3. LabCentral Adds Eppendorf as a Major Sponsor of the Cambridge Launchpad for Life Science Startups
4. 2013 Neurotech Leaders Forum to Feature Promising New Startups
5. Ultra Light Startups Hosts Future Energy Investor Feedback Forum at MIT
6. Midwest Healthcare Startups Raise $996 Million in 2012
7. CureLauncher is Described on LIVESTRONG Blog as Modern Platform That Gets People Involved in Advancing New Cancer Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on ... of Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ... is expected to deliver therapeutic levels of olanzapine for a period of 3 months., ...
(Date:2/24/2017)... SAN DIEGO , Feb. 24, 2017  Aethlon ... the following note authored by its Chairman and CEO, ... address at the Munich Security Conference last Saturday, ... engineered virus could kill more people than nuclear weapons. ... by U.S. and U.K. intelligence agencies, that scientific terrorists ...
(Date:2/24/2017)... China Cord Blood Corporation (NYSE: ... of cord blood collection, laboratory testing, hematopoietic stem cell ... unaudited financial results for the third quarter and first ... 2016. Third Quarter of Fiscal 2017 Highlights ... fiscal 2017 increased by 18.6% to RMB200.9 million ($28.9 ...
(Date:2/24/2017)... Corporation (NASDAQ: VWR), the leading global independent provider of product ... its financial results for the fourth quarter and full year ... 4Q16 record quarterly net sales of $1.13 billion, up ... 4Q16 EMEA-APAC segment net sales increased ... net sales increased 2.5%, or down 0.9% on an organic ...
Breaking Biology Technology:
(Date:2/9/2017)... , Feb. 9, 2017 The biomass boiler ... of the biomass boiler market globally in terms of ... biomass boilers. The market for biomass boilers has been ... end-user, application, and country/region. The market based on feedstock ... forest residues, biogas & energy crops, urban residues, and ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/8/2017)... , Feb. 7, 2017 The ... largely by the confluence of organizations, desires to ... for knowledge-based systems (password and challenge questions), biometrics ... and government systems. The market is driven by ... demarcation between consumer and enterprise uses cases, with ...
Breaking Biology News(10 mins):